Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jun 15, 2022 10:00 AM - Jun 15, 2022 1:00 PM

(Eastern Standard Time)

R&D QA Comprehensive Quality Strategy: An Approach to Managing Quality Risks throughout the Drug Development Lifecycle

Instructors

Matt  Burtt, MBA

Matt Burtt, MBA

Director Clinical QA, AbbVie, United States

After completing a Biomedical Engineering undergraduate degree, I built upon my internship with Abbott (eventually AbbVie) in a 2 year rotational program with different assignments every six months across the business landscape. Since then I've been in the R&D Quality Assurance world, added an MBA and spent the last 6 years helping to build a "Program Management" team in GCP QA. We have aggressively sought opportunities to drive proactive QA in the Development / Clinical landscape via fully embracing the integrated Quality System approach. Our team members support all compounds/assets with a strategic Quality mindset. Critical thinking, Risk and Issue Management have led to successful submissions, inspections and approvals.

Arun  Mathew, MBA, MSC

Arun Mathew, MBA, MSC

Director , Abbvie, United States

Business process owner for quality risk management in R&D(2.6yrs) Risk Management experience(19 yrs.) Medical devices experience (16yrs). Contributed and reviewed the book Foundations of Quality Risk Management.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.